Cargando…

Effects of Ulinastatin on Myocardial Ischemia-Reperfusion Injury, Cardiac Function, and Serum TNF-α and IL-10 Levels in Patients Undergoing Cardiac Valve Replacement under Cardiopulmonary Bypass

BACKGROUND: Myocardial ischemia-reperfusion injury (MIRI) is a very common adverse reaction after cardiac valve replacement (CVR) under cardiopulmonary bypass, which seriously affects the rehabilitation and prognosis of patients. OBJECTIVE: The prevention and treatment of MIRI are a hotspot of moder...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Hai, Zhang, Dafa, Qian, Hongbo, Nie, Jun, Wei, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993558/ https://www.ncbi.nlm.nih.gov/pubmed/35401778 http://dx.doi.org/10.1155/2022/1823398

Ejemplares similares

Retracted: Effects of Ulinastatin on Myocardial Ischemia-Reperfusion Injury, Cardiac Function, and Serum TNF-α and IL-10 Levels in Patients Undergoing Cardiac Valve Replacement under Cardiopulmonary Bypass
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Effects of ulinastatin treatment on myocardial and renal injury in patients undergoing aortic valve replacement with cardiopulmonary bypass
por: Oh, Se-young, et al.
Publicado: (2012)

Ulinastatin treatment and renal injury in patients undergoing aortic valve replacement with cardiopulmonary bypass. A note of aution
por: Lema, Guillermo
Publicado: (2013)

Effects of Ulinastatin on Postoperative Blood Loss and Hemostasis in Atrioventricular Valve Surgery with Cardiopulmonary Bypass
por: Park, Jae Bum, et al.
Publicado: (2013)

Lack of Efficacy of Ulinastatin Therapy During Cardiopulmonary Bypass Surgery
por: Qiu, Yan, et al.
Publicado: (2015)

Modified cardiopulmonary bypass with low priming volume for blood conservation in cardiac valve replacement surgery
por: Yang, Ke, et al.
Publicado: (2023)

Lund exhaust on hemodynamic parameters and inflammatory mediators in patients undergoing cardiac valve replacement under cardiopulmonary bypass
por: Zhu, Jihong, et al.
Publicado: (2018)

High-dose ulinastatin improves postoperative oxygenation in patients undergoing aortic valve surgery with cardiopulmonary bypass: A retrospective study
por: Rhee, Ka-Young, et al.
Publicado: (2018)

Effects of Ulinastatin on Postoperative Renal Function in Patients Undergoing Cardiac Surgery with Cardiopulmonary Bypass: A Prospective Cohort Study with 10-Year Follow-Up
por: Lv, Huanran, et al.
Publicado: (2023)

Effects of Different Anesthetics on Perioperative Organ Protection and Postoperative Cognitive Function in Patients Undergoing Cardiac Valve Replacement with Cardiopulmonary Bypass
por: Mei, Shenglan, et al.
Publicado: (2022)

Neuroprotective Effect of Ulinastatin on Spinal Cord Ischemia-Reperfusion Injury in Rabbits
por: Liu, Bingbing, et al.
Publicado: (2015)

Retracted: Effects of Different Anesthetics on Perioperative Organ Protection and Postoperative Cognitive Function in Patients Undergoing Cardiac Valve Replacement with Cardiopulmonary Bypass
por: Intelligence and Neuroscience, Computational
Publicado: (2023)

Efficacy of dexmedetomidine on myocardial ischemia/reperfusion injury in patients undergoing cardiac surgery with cardiopulmonary bypass: A protocol for systematic review and meta-analysis
por: Liang, Gencheng, et al.
Publicado: (2023)

Effect of high-dose ulinastatin on the cardiopulmonary bypass-induced inflammatory response in patients undergoing open-heart surgery
por: Liu, Yu, et al.
Publicado: (2020)

Effect of Urinary Protease Inhibitor (Ulinastatin) on Cardiopulmonary Bypass: A Meta-Analysis for China and Japan
por: Zhang, Yun, et al.
Publicado: (2014)

Cardiopulmonary resuscitation with cardiopulmonary bypass after cardiac surgery
por: Rodrigus, I, et al.
Publicado: (2000)

Difficulty Weaning From Cardiopulmonary Bypass Following an Aortic Valve Replacement
por: Korelidis, George, et al.
Publicado: (2023)

Effects of ulinastatin and docataxel on breast tumor growth and expression of IL-6, IL-8, and TNF-α
por: Zhao, Xiaoliang, et al.
Publicado: (2011)

Ulinastatin Protects against Acute Kidney Injury in Infant Piglets Model Undergoing Surgery on Hypothermic Low-Flow Cardiopulmonary Bypass
por: Wang, Xiaocou, et al.
Publicado: (2015)

The effect of Ulinastatin on postoperative course in cardiopulmonary bypass patients in Asia: a meta-analysis of randomized controlled trials
por: Zhenyu, Hu, et al.
Publicado: (2022)

Circulating small extracellular vesicle-encapsulated SEMA5A-IT1 attenuates myocardial ischemia–reperfusion injury after cardiac surgery with cardiopulmonary bypass
por: Wu, Ting, et al.
Publicado: (2022)

STAT3 Regulates Monocyte TNF-Alpha Production in Systemic Inflammation Caused by Cardiac Surgery with Cardiopulmonary Bypass
por: de Jong, Petrus R., et al.
Publicado: (2012)

Renal Outcome in Patients Undergoing Cardiac Surgery Using Cardiopulmonary Bypass
por: Alqarni, Mohammed S, et al.
Publicado: (2020)

Ulinastatin to prevent acute kidney injury after cardiopulmonary bypass surgery: does serum creatinine tell the whole story?
por: Honore, Patrick M., et al.
Publicado: (2016)

Effect of ulinastatin on post-operative blood loss and allogeneic transfusion in patients receiving cardiac surgery with cardiopulmonary bypass: a prospective randomized controlled study with 10-year follow-up
por: Zhang, Peng, et al.
Publicado: (2020)

A Cardiac Protection of Germinated Brown Rice During Cardiopulmonary Bypass Surgery and Simulated Myocardial Ischemia
por: Demeekul, Kanokwan, et al.
Publicado: (2021)

Clinical applications of retrograde autologous priming in cardiopulmonary bypass in pediatric cardiac surgery
por: Fu, G.W., et al.
Publicado: (2016)

Postoperative complications following cardiac surgery with cardiopulmonary bypass
por: Atwell, DM, et al.
Publicado: (1997)

Neuroprotective Strategies during Cardiac Surgery with Cardiopulmonary Bypass
por: Salameh, Aida, et al.
Publicado: (2016)

Cardiac operation under cardiopulmonary bypass during pregnancy
por: Liu, Yanli, et al.
Publicado: (2020)

Custodiol-N, the novel cardioplegic solution reduces ischemia/reperfusion injury after cardiopulmonary bypass
por: Veres, Gábor, et al.
Publicado: (2015)

Deficiency of Interleukin-36 Receptor Protected Cardiomyocytes from Ischemia-Reperfusion Injury in Cardiopulmonary Bypass
por: Luo, Cheng, et al.
Publicado: (2020)

Multi-organ protection of ulinastatin in traumatic cardiac arrest model
por: Liu, Shaoyun, et al.
Publicado: (2018)

Changes in the concentrations of mediators in exhaled breath condensate during cardiac valve replacement under cardiopulmonary bypass and their relations with postoperative acute respiratory distress syndrome
por: Song, Jie, et al.
Publicado: (2020)

Comparison of ringer's lactate and plasmalyte-a as cardiopulmonary bypass prime for bypass associated acidosis in valve replacement surgeries
por: Surabhi, Sandill, et al.
Publicado: (2021)

Levosimendan enhances cardiac performance in patients following cardiac surgery and cardiopulmonary bypass
por: Sandell, E-P, et al.
Publicado: (2002)

Prediction of outcome in patients undergoing cardiac surgery on cardiopulmonary bypass using procalcitonin
por: Dörge, H, et al.
Publicado: (1999)

Effects of Pre–Cardiopulmonary Bypass Administration of Dexmedetomidine on Cardiac Injuries and the Inflammatory Response in Valve Replacement Surgery With a Sevoflurane Postconditioning Protocol: A Pilot Study
por: Zhou, Hongmei, et al.
Publicado: (2019)

Postconditioning improvement effects of ulinastatin on brain injury following cardiopulmonary resuscitation
por: SUI, BO, et al.
Publicado: (2014)

Clinical observation of ulinastatin combined with CRRT in the treatment of early cardiopulmonary resuscitation
por: Liu, Qinghong, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pgubi365tsijndobklvvbg4sev